Latest Zofran Child Birth Defect Lawsuits
21 April 2015

Wisconsin Zofran Birth Defects Data & Litigation

What Is Zofran?

Zofran is a drug that was once authorized by the Food and Drug Administration (FDA) in 1991 as a medication to be used alone or with other drugs for the prevention of nausea and vomiting brought about by cancer drug treatment and radiation therapy. It was also certified for use by people who want to avoid or are suffering from nausea and vomiting after surgery.

Zofran is designed to block serotonin, one of the body’s natural substances that is known to cause vomiting. Unfortunately, Zofran was being misused and marketed for use to prevent serious morning sickness in expectant mothers. If Zofran was taken in the first twelve weeks of pregnancy, clinical studies have shown there are side effects that are linked to the drug that cause birth deformities. By 2000, the manufacturer of the drug GSK, was made aware of 32 documented birth abnormalities that were caused by a mom taking Zofran during the early months of her pregnancy.

Wisconsin: Birth Abnormality Stats

The Wisconsin Department of Health Services reports that nearly 2,000 babies are born with some form of abnormality each year. The Wisconsin Department of Health Services has detailed information about birth abnormalities, click here for more information. In 2014 the U.S.A Census Bureau reported Wisconsin’s population as 5,757,564. The following are the five most heavily populated Wisconsin cities.

  • Milwaukee- 599,164 population
  • Madison- 243,344 population
  • Green Bay- 104,779 population
  • Kenosha- 99,889 population
  • Racine- 78,199 population

The Center for Disease Control and Prevention (CDC) approximates a one in 33 chance of a baby being born with a birth defect. Considering these approximations and year in which Zofran became ‘active’ on the market (1991), our Zofran attorneys have processed probable figures of the potential number of live births that were impacted by Zofran resulting in an abnormality, at the same time using the average risk proportions recognized in the Zofran related studies. This calculation led to an approximate figure of 3,200 births in Wisconsin that were affected by Zofran being present in utero in the first twelve weeks of pregnancy.

Number Of Cleft Lip & Palate Defects & CHDs Affiliated With Zofran In Wisconsin

Using the  Wisconsin population of 5,757,564 as a base, we estimate that of the 3,200 births affected by Zofran in the state, 540 births are a form of cleft palate / lip and 2,660 are ASD or VSD (also known as congenital heart defects or CHDs).For the five most heavily populated Wisconsin cities these defects are as follows:

  • Milwaukee- 330 birth irregularities with nearly 55 cleft lip/palate, and 275 CHDs
  • Madison- 165 birth irregularities with nearly 25 cleft lip/palate, and 140 CHDs
  • Green Bay- 100 birth irregularities with nearly 10 cleft lip/palate, and 90 CHDs
  • Kenosha- 97 birth irregularities with nearly 10 cleft lip/palate, and 87 CHDs
  • Racine- 87  birth irregularities with nearly 8 cleft lip/palate, and 79 CHDs

Documented Zofran Birth Deformities

GSK has disregarded the various clinical investigations performed on the effects Zofran has on an unborn child, as they continue to deny that their drug causes and has caused birth deformities. However, cases that have so far been brought to court state otherwise. The following are the deformities that complainants say were caused by taking Zofran:

To further prove the effects of Zofran on an unborn child, CDC and Sloan Epidemiology released a study that concluded that there is a 2.37 likelihood of a baby being born with a cleft palate if a mom consumed Zofran in the first twelve weeks of pregnancy.Read the study here.

Wisconsin Parents Seeking Justice

The website was developed and funded by the law firms of Monheit Law, Janet Jenner & Suggs, Grant Eisenhofer, Markhoff & Mittman and Banville Law, in order to provide relevant information related to the Zofran lawsuit. Although our advocacy team is not authorized to practice law in Wisconsin, we are authorized to practice and hold offices in Delaware. Delaware state is where Zofran manufacturer GSK, is headquartered. Having offices in Delaware enables us to work on behalf of your family if a lawsuit is filed in Delaware.

Wisconsin parents have been in contact with us because they suspect their child’s birth abnormality happened because the expectant mom took Zofran for serious morning sickness in her early pregnancy weeks. We know circumstances are different, therefore, we may advise you to file your case in Delaware or file in Wisconsin using our personally approved Wisconsin legal representatives.

We are here to answer any and all questions you may have regarding this litigation- so please call us.Our lawyers are ready to speak with you at any time of the day. Get to know our lawyers here.

Where To Acquire Information About Cleft Palate Defects & CHD

Call Now Button